Jun An Kang Group Inc. (IHGP)
OTCMKTS · Delayed Price · Currency is USD
0.0147
-0.0014 (-8.70%)
Aug 22, 2025, 2:11 PM EDT
Jun An Kang Group Market Cap
Jun An Kang Group has a market cap or net worth of $24.70 million as of August 22, 2025. Its market cap has decreased by -46.18% in one year.
Market Cap
24.70M
Enterprise Value
n/a
Revenue
4.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since December 7, 2005, Jun An Kang Group's market cap has decreased from 104.00M to 24.70M, a decrease of -76.25%. That is a compound annual growth rate of -7.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 24.70M | -91.35% |
| Dec 31, 2024 | 285.59M | 1,197.89% |
| Dec 22, 2023 | 22.00M | 26.58% |
| Dec 30, 2022 | 17.38M | -22.74% |
| Dec 31, 2021 | 22.50M | 4,508,689.58% |
| Dec 31, 2020 | 499.00 | 153.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |